Crossmark

Study Protocol for Pleiotropic Effects and Safety of Sodium–Glucose Cotransporter 2 Inhibitor Versus Sulfonylurea in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

Crossref DOI link: https://doi.org/10.1007/s13300-020-00762-9

Published Online: 2020-01-20

Published Print: 2020-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Takeshita, Yumie

Kanamori, Takehiro

Tanaka, Takeo

Kaikoi, Yuka

Kita, Yuki

Takata, Noboru

Iida, Noriho

Arai, Kuniaki

Yamashita, Tatsuya

Harada, Kenichi

Gabata, Toshifumi

Nakamura, Hiroyuki

Kaneko, Shuichi

Takamura, Toshinari https://orcid.org/0000-0002-4393-3244
Funding

Funding for this research was provided by:

Grants-in-Aid from the Ministry of Education, Culture (19K08975)

Kowa Company Ltd
License Information

Text and Data Mining valid from 2020-01-20

Version of Record valid from 2020-01-20
More Information

Article History

Received: 26 November 2019

First Online: 20 January 2020

Document is current

Any future updates will be listed below